TXT
65
-3
GT
26
2
CRM
47
8
PLD
28
-2
MS
58
-4
ROST
62
-4
PCG
72
-5
AVGO
40
-5
PX
73
-2
COST
51
-2
IBM
50
2
OI
38
-4
TROW
40
-2
LEN
59
2
HON
62
9
BMY
50
2
NEE
54
8
MTCH
84
-6
SWK
64
-4
TSCO
70
2
TXT
65
-3
GT
26
2
CRM
47
8
PLD
28
-2
MS
58
-4
ROST
62
-4
PCG
72
-5
AVGO
40
-5
PX
73
-2
COST
51
-2
IBM
50
2
OI
38
-4
TROW
40
-2
LEN
59
2
HON
62
9
BMY
50
2
NEE
54
8
MTCH
84
-6
SWK
64
-4
TSCO
70
2
Financhill
Back

Apellis Pharmaceuticals Vs. Nukkleus- Ordinary Shares - New Industry Stock Comparison

Buy
67

APLS
Apellis Pharmaceuticals

Last Price:
$27.77
Seasonality Move:
-1.34%
Sell
8

NUKK
Nukkleus- Ordinary Shares - New

Last Price:
$4.07
Seasonality Move:
-16.22%
Buy
67
Apellis Pharmaceuticals (APLS) is a Buy

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $27.75. The Score for APLS is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
8
Nukkleus- Ordinary Shares - New (NUKK) is a Sell

Is Nukkleus- Ordinary Shares - New a Buy, Sell or Hold?

  • The current Nukkleus- Ordinary Shares - New [NUKK] share price is $4.10. The Score for NUKK is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $27.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

NUKK Stock Price Chart

What is Nukkleus- Ordinary Shares - New's stock price today?

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.98 Buy
Relative Strength Index (14 RSI): 80.09 Buy
Chaikin Money Flow: -3127136 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.17 - 24.81) Buy
Bollinger Bands (100): (17.13 - 22.13) Buy

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.98 Buy
Relative Strength Index (14 RSI): 24.13 Sell
Chaikin Money Flow: -66878 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.87 - 8.21) Sell
Bollinger Bands (100): (7.95 - 15.79) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.27 Buy
20-day SMA: 22.57 Buy
50-day SMA: 20.23 Buy
200-day SMA: 24.53 Buy
8-day EMA: 25.55 Buy
20-day EMA: 23.35 Buy
50-day EMA: 21.29 Buy
200-day EMA: 25.02 Buy

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.57 Sell
20-day SMA: 6.19 Sell
50-day SMA: 8.88 Sell
200-day SMA: 13.52 Sell
8-day EMA: 4.39 Sell
20-day EMA: 3.69 Buy
50-day EMA: 2.18 Buy
200-day EMA: 0.68 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.18 per share, a decrease next quarter of $1.21 per share, an increase this year of $1.33 per share, and a decrease next year of $0.70 per share.

Nukkleus- Ordinary Shares - New Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus- Ordinary Shares - New Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):